Category Cancer Types

5
Dec

KCC’s 3rd Annual Men’s Event

Another successful year! The Kimmel Cancer Center hosted its 3rd annual Men’s Event at the Prime Rib in Philadelphia on November 15. About 150 people joined Richard Pestell, M.D., Ph.D., Director, Kimmel Cancer Center at Jefferson, Leonard Gomella, M.D., Chair, Department of Urology at Jefferson and 2011 Men’s Event Co-Chairs Edward Glickman, President of Pennsylvania …

8
Nov

Kimmel Cancer Center Hosts Interurban Clinical Club

On Friday, October 28, the Kimmel Cancer Center at Jefferson hosted the 204th meeting of the Interurban Clinical Club at Jefferson Medical College of Thomas Jefferson University. The Interurban Clinical Club is a prestigious club founded by Sir William Osler in 1905 for the purpose of exchanging ideas and fellowship among medical teachers in some …

31
Oct

Gordon Schwartz, M.D., Nominated to National Accreditation Program for Breast Centers Board

Gordon F. Schwartz, MD, MBA, FACS, director of the Jefferson Breast Care Center, will represent the American Society of Breast Disease on the board of the National Accreditation Program for Breast Centers (NAPBC). The NAPBC is a consortium of national, professional organizations dedicated to the improvement of the quality of care and the monitoring of …

28
Oct

Surgeons Cut Whipple Procedure Wound Infections in Half with New Measures

Thomas Jefferson University Hospital surgeons found that a carefully-selected surgical care check list of 12 measures reduced Whipple procedure wound infections by nearly 50 percent. Smoking cessation at least two weeks prior to surgery, gown and glove change prior to skin closure, and using clippers over razors to shave the surgical area are some of the …

14
Oct

Ulrich Rodeck receives Ben Franklin-PCF Creativity Award

Ulrich Rodeck, M.D., Ph.D., a professor in the Department of Dermatology and Cutaneous Biology, at Jefferson Medical College, Thomas Jefferson University, received the Ben Franklin-Prostate Cancer Foundation Creativity award for his work in improving the therapeutic window of radiation therapy for prostate cancer. Radiation therapy of locally advanced prostate cancer is associated with severe toxicity …

13
Oct

Jefferson-Eagles Breast Health Floor Dedication Event

On October 11, the Jefferson Breast Care Center unveiled the Jefferson-Philadelphia Eagles Breast Health floor with a ribbon-cutting ceremony. The speakers were Jefferson President and CEO Tom Lewis, Director of the Kimmel Cancer Center at Jefferson Dr. Richard Pestell, Eagles owner Christina Lurie, Eagles safety Kurt Coleman and breast cancer survivor Caity Buck. Earlier this year, …

29
Sep

Kimmel Cancer Center at Jefferson Celebrates 20 Years of Patient Care and Cancer Discovery

From October forward, the Kimmel Cancer Center at Jefferson (KCC), a National Cancer Institute-designated cancer center, is celebrating 20 years of service to the community and the groundbreaking cancer research from the scientists and physicians who’ve provided an invaluable contribution to medical science and healthcare. “This is truly a milestone for the Kimmel Cancer Center—it’s …

23
Sep

Dr. Michael Lisanti’s Cancer Research Featured in New Scientist

New cancer research suggests that we have misunderstood the feeding habits of cancer for decades, wrongly believing that cancer cells produce the bulk of their energy by breaking down glucose in the absence of oxygen, known as the Warburg effect. Dr. Michael Lisanti of the Kimmel Cancer Center at Jefferson proposes that when a cell turns cancerous …

22
Sep

New Half-Match Bone Marrow Transplant Procedure Featured in Philadelphia Inquirer

Neal Flomenberg, M.D., chair of the Department of Medical Oncology at Jefferson and Dolores Grosso, DNP, co-principal investigator of the study, have developed a way to make stem-cell transplants work, even when only half the immune markers are matched. Featured in the “Check Up” section of The Philadelphia Inquirer, this research has major implications. Half-match transplants would triple …

8
Sep

Half-Match Bone Marrow Transplant Procedure Yields Promising Outcomes for Cancer Patients

Half-matched bone marrow or stem cell transplants for blood cancer patients have typically been associated with disappointing clinical outcomes. However, a clinical trial conducted at the Kimmel Cancer Center at Jefferson testing its unique, two-step half-match procedure has produced some promising results: the probability of overall survival was 45 percent in all patients after three years …

31
Aug

Edith Mitchell Talks to WHYY Radio about African American Doctors in Medicine

Jefferson medical oncologist Edith Mitchell, M.D., FACP, works on diversity efforts as associate director of Diversity Services for the Kimmel Cancer Center at Jefferson. In a recent WHYY Radio interview, Dr. Mitchell shares some of her experiences with African American patients and gives her perspective on race and medicine today. She believes that listening to patients …

29
Aug

Robert B. Den, M.D., Joins the Department of Radiation Oncology at Jefferson

Radiation oncologist Robert B. Den, M.D., recently joined Thomas Jefferson University Hospital as an attending physician, and was also named an assistant professor at Jefferson Medical College of Thomas Jefferson University in the Department of Radiation Oncology. Dr. Den is a clinical scientist who specializes in the treatment of prostate cancer, combining his laboratory research …

26
Aug

A Tumor Suppressor May Also Fight Obesity

The hormone receptor guanylyl cyclase C (GCC) has been established as a suppressor of colorectal cancer tumors, but new evidence from Thomas Jefferson University suggests it may also help fight one of the country’s biggest pandemics: obesity. Reporting in the August 25 online issue of the Journal of Clinical Investigation, Scott Waldman, M.D., Ph.D., chairman …

25
Aug

ADVANCE for Nurses Magazine Features KCC’s Senior Adult Oncology Center

The multidisciplinary staff at the Center assesses the many health challenges confronting senior adults and recommends a personalized cancer treatment plan for each patient. Jefferson staff members Pat Dugan, Vicki Squire and Barb Daulerio were interviewed for the article. The nursing magazine, ADVANCE for Nurses, put the spotlight recently on the Senior Adult Oncology Center …

12
Aug

Blocking Receptor in Key Hormone Fires Up Enzyme to Kill Pancreatic Cancer Cells

Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division. With that, a new chemopreventive agent that inhibits the …

2
Aug

Leukemia Drug Reverses Tamoxifen-Resistance in Breast Cancer Cells

Taking a leukemia chemotherapy drug may help breast cancer patients who don’t respond to tamoxifen overcome resistance to the widely-used drug, new research from the Kimmel Cancer Center at Jefferson suggests. Interestingly, researchers found that tamoxifen combined with dasatinib, a protein-tyrosine kinase inhibitor, reverses the chemo-resistance caused by cancer-associated fibroblasts in the surrounding tissue by …

7
Jul

Dr. Greenbaum to co-organize International Conference on Liver Biology

Dr. Linda Greenbaum will co-organize, (along with Dr. Jessica Zucman-Rossi (Professor of Medicine (Oncology), University of Paris Descartes), the 2012 FASEB Summer Research Conference  on “Liver Biology: Fundamental Mechanisms & Translational Applications.  The conference will take place in Snowmass, Colorado July 29-August 3, 2012 and will bring together 150- 200 outstanding basic and translational scientists dedicated …

7
Jul

Dr. Greenbaum selected as Chair of AASLD/ALF Joint Grant Review Committee

Dr. Linda Greenbaum was selected as the  Chair of the  American Association for the Study of Liver Diseases (AASLD)/ American Liver Foundation (ALF) joint grant review committee for the term 2011-14.

5
Jul

Radiation after prostate removal is cost-effective, but less likely to be recommended by urologists

Receiving radiation therapy immediately after a radical prostatectomy is a cost-effective treatment for prostate cancer patients when compared with waiting and acting on elevated prostate-specific antigen (PSA) levels, according to a new study by researchers at Thomas Jefferson University and Hospital. What’s more, a separate, but related study, found that urologists were less likely than …

23
Jun

Director of KCC, Dr. Richard Pestell, in July issue of Runner’s World

Dr. Richard Pestell, director of the Kimmel Cancer Center at Jefferson and former national-class distance runner, was featured in the July issue of Runner’s World. Dr. Pestell spoke with the magazine for the cover story titled “Outrunning Cancer”–which focused on the running community’s ability to raise million of dollars each year to fight cancer. “When …

10
Jun

Edith Mitchell Receives ‘Practitioner of the Year’ Award from Philadelphia County Medical Society

Edith Mitchell, M.D., clinical professor of Medicine and Medical Oncology at Jefferson Medical College of Thomas Jefferson University, was named 2011 “Practitioner of the Year” Award by the Philadelphia County Medical Society (PCMS). For her excellence in clinical care and community service, Dr. Mitchell will be presented the award on Saturday, June 11, during the …

8
Jun

Melanoma Awereness Night At The Philles Organized By Kelly Kroll and the “Bonnie Kroll Melanoma Memorial Fund”

May is Melanoma Awareness Month. Kelly Kroll of Ambler PA has set up the “Bonnie Kroll Melanoma Memorial Fund” in honor of her mother who died in 2001 from uveal melanoma. The fund has raised over $150,000 to support research at the the Thomas Jefferson University Hospital and the Kimmel Cancer Center of Thomas Jefferson …

1
Jun

Dr. Karen Knudsen Receives Ron Ross Award

See the Award Announcement for more information about the Award and its latest recipient. The following was abstracted from the announcement. Dr. Karen Knudsen of the Kimmel Cancer Center received the Ron Ross Award at the 5th Pacific Rim Breast and Prostate Cancer Meeting, held in Kingscliff, Australia, May 3-7, 2011. Dr. Ron Ross was …

1
Jun

KCC Research: Cancer Cells Accelerate Aging & Inflammation in Body to Drive Tumor Growth

Researchers at the Kimmel Cancer Center at Jefferson have shed new light on the longstanding conundrum about what makes a tumor grow—and how to make it stop.  Interestingly, cancer cells accelerate the aging of nearby connective tissue cells to cause inflammation, which ultimately provides “fuel” for the tumor to grow and even metastasize. This revealing …

23
May

Highlights from KCC American Cancer Society Research Symposium

The Kimmel Cancer Center at Jefferson hosted the 3rd Annual American Cancer Society Research Symposium: Celebrating the ACS Institutional Research Grant at KCC on May 6, 2011. Dr. Nevalainen welcomed members of the KCC and TJU community and the American Cancer Society. Richard Pestell, MD, PhD gave the Keynote Address, “Cancer Invasion and Metastasis and …

19
May

Marker Identifies Breast Cancer Patients Likely to Respond to Tamoxifen

ER positive breast cancer patients whose tumors have active protein Stat5 have increased likelihood of responding to anti-estrogen therapy PHILADELPHIA—Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy. The research appears …

17
May

Dr. Sato Recieves Generous Gift For Uveal Melanoma Research

Benefactors Mark and Alison Weinzierl pose with Kimmel Cancer Center Director Dr. Richard G. Pestell (R) and Dr. Takami Sato (L), Professor of Medical Oncology and director of the Uveal Melanoma research program at the KCC.  The Weinzierls (from the Dallas, Texas, area) are providing $1 million in support of Dr. Sato’s work.

6
May

KCC American Cancer Society Research Symposium

The 3rd Annual Kimmel Cancer Center American Cancer Society Research Symposium will be held today at 2 p.m. in 101 BLSB. KCC Director Richard Pestell, M.D, Ph.D, will present the keynote address and 2010 American Cancer Society-Institutional Research Grant Award recipients. Amy Leader, DrPH, MPH, and Hushan Yang, Ph.D, will discuss their research. A reception …

26
Apr

KCC Team to Walk for Bladder Cancer

It is estimated that more than 70,000 new cases of bladder cancer were diagnosed in 2010, making it the 5th most commonly diagnosed cancer in the U.S. Please join Dr. Jean Hoffman-Censits, of the Department of Medical Oncology, Solid Tumor Division, and the Kimmel Cancer Center at Jefferson Team in raising awareness of the disease …

19
Apr

Dr. Edith Mitchell attends National Summit on Health Disparities, Hon. Nancy Pelosi and Sen. Harry Reid honored

Edith Mitchell, M.D., clinical professor of Medicine and Medical Oncology at Jefferson Medical College of Thomas Jefferson University, attended the 8th Annual National Summit on Health Disparities Meeting & Awards Dinner in Washington, D.C., on April 11 and 12. The summit, organized by The National Minority Quality Forum and the Congressional Black Caucus Foundation, in …

19
Apr

Jefferson Researchers Unlock Key to Personalized Cancer Medicine Using Tumor Metabolism

Identifying gene mutations in cancer patients to predict clinical outcome has been the cornerstone of cancer research for nearly three decades, but now researchers at the Kimmel Cancer Center at Jefferson have invented a new approach that instead links cancer cell metabolism with poor clinical outcome. This approach can now be applied to virtually any …

13
Apr

Jefferson Doctors Strengthen Case for High-Dose Radiotherapy Technique After Radical Prostatectomy

A widely-available yet expensive radiotherapy technique used to treat prostate cancer patients after surgery has promising benefits—higher dose and less damage to the rectum and bladder—compared to a less precise technique, Thomas Jefferson University researchers document for the first time in a new study published in Practical Radiation Oncology. A team of radiation oncologists and …

7
Apr

Celebrating National Cancer Registrars Week

Cancer Registrars throughout the United States and abroad will join their colleagues, community leaders, and other medical professionals to observe the 15th annual National Cancer Registrars Week, April 11th-15th. Quality cancer data is central to the nation’s fight against cancer, and cancer registrars are the first link in capturing these data. Our Cancer Registry works …

6
Apr

Kimmel Cancer Center at Jefferson breast cancer symposium features latest in research, treatment

The latest advances in both breast cancer treatment and research – including innovations in diagnostic, surgical, chemotherapy and radiation approaches – will be discussed Friday, April 8, 2011, at a breast cancer symposium at the Kimmel Cancer Center at Jefferson in Philadelphia. The all-day, breast cancer symposium, part of an annual series at the Kimmel …

22
Mar

Jefferson Clinical Trial: Can a Cholesterol Drug Prevent Colon Cancer?

Thomas Jefferson University has started recruiting patients for a new National Cancer Institute (NCI)-sponsored clinical trial to test whether the cholesterol-reducing drug rosuvastatin is effective in the prevention of recurrent colon cancer. Previous laboratory research and population studies have shown that patients taking statins, the class of drugs that lowers cholesterol, had fewer colon polyps, …

10
Mar

Jefferson Researchers Unravel Protein’s Elusive Role in Embryo and Disease Development in Nature

Reporting in Nature, scientists from Thomas Jefferson University have determined that a single protein called FADD controls multiple cell death pathways, a discovery that could lead to better, more targeted autoimmune disease and cancer drugs. Twelve years ago, internationally-known immunologistan associate professor in the Department of Microbiology and Immunology at Thomas Jefferson University, realized FADD, …

1
Mar

Radiation Oncology Announcements and Appointments

New faculty: Thomas Jefferson University welcomes two new, seasoned clinicians and researchers to its Department of Radiation Oncology: Nicole Simone, M.D., from the National Institutes of Health’s National Cancer Institute (NCI) and Bo Lu, M.D., Ph.D, from Vanderbilt University. Dr. Simone is a board-certified Radiation Oncologist who has treated mostly patients with breast and head …

22
Feb

“Longevity” Protein SIRT1 May Ward Off Precursor to Prostate Cancer

Researchers from the Kimmel Cancer Center at Jefferson and two other institutions have discovered new evidence that suggests the “longevity” protein SIRT1, known for its life-spanning effects in different species, can inhibit the development of a known precursor to prostate cancer, prostatic intraepithelial neoplasia (PIN). “Prostate cancer is one of the malignancies that has a …

21
Feb

Dr. Leonard Gomella co-chairs ASCO GU in Orlando

Dr. Leonard G. Gomella, chair of the Department of Urology and director of Clinical Affairs at the Kimmel Cancer Center at Jefferson, co-chaired the American Society of Clinical Oncology (ASCO) 2011 Genitourinary (GU) Cancers Symposium meeting in Orlando on Feb. 17 though Feb. 19. The “2011 Genitourinary Cancers Symposium: An Evidence-based Multidisciplinary Approach,” was a …

16
Feb

Shifting a paradigm: A molecular approach to staging colorectal cancer

A quantitative, molecular analysis of lymph nodes in patients deemed colorectal cancer-free was found to be an effective predictor of recurrence, according to a study from researchers at the Kimmel Cancer Center at Jefferson and published online Feb 9. in Clinical Cancer Research. Recurrence occurs in about 25 percent of node-negative patients (pN0), suggesting that …

15
Feb

Researchers Say Stress Fuels Cancer Growth, Provide Genetic Evidence That Antioxidants Can Help Treat It

Researchers from Jefferson’s Kimmel Cancer Center have genetic evidence suggesting the antioxidant drugs currently used to treat lung disease, malaria and even the common cold can also help prevent and treat cancers because they fight against mitochondrial oxidative stress—a culprit in driving tumor growth. For the first time, the researchers show that loss of the …

11
Feb

New Tumor Tracking Technique for Radiotherapy Spares Healthy Tissue, Could Improve Cancer Treatment

Medical physicists at Thomas Jefferson University and Jefferson’s Kimmel Cancer Center have demonstrated a new real-time tumor tracking technique that can help minimize the amount of radiation delivered to surrounding healthy tissue in a patient—up to 50 percent less in some cases—and maximize the dose the tumor receives. Respiratory and cardiac motions have been found …

10
Jan

Giovanni M. Pitari, M.D., Ph.D. receives award from the American Institute for Cancer Research

Giovanni M. Pitari, M.D., Ph.D., has received an award from the American Institute for Cancer Research to support his research project entitled ‘Therapeutic Synergy between Dietary Calcium and Bacterial Enterotoxins for the Prevention and Treatment of Colon Cancer’. The award provides research funding directed toward discovering innovative therapeutic modalities for cancer prevention and cure. Dr. …

20
Dec

2010 Men’s Event Recap

On Tuesday, November, 16th 2010, the Kimmel Cancer Center at Jefferson held the Second Annual Men’s Event at the Prime Rib Restaurant in Philadelphia. The Men’s Event was emceed by Comedian Joe Piscopo. The inaugural Kimmel Cancer Center Men’s Event “Man of the Year Award”  was awarded to Mr. Kenneth Gamble, a world-renowned Grammy winning …

24
Nov

Loss of the retinoblastoma tumor suppressor pushes prostate cancer into lethal stage, say Kimmel Cancer Center researchers

Their study, the first to uncover a new role for this powerful gene, may lead to clinical “barcoding” of a patient’s prostate cancer to help direct therapy (PHILADELPHIA) – The retinoblastoma tumor suppressor gene (Rb), long thought to protect cells against cancer development, appears to play a very different role in prostate cancer, say scientists …

18
Nov

2010 Breast Health International Breast Cancer Consensus Conference

On Friday, October 22 through Sunday, October 24, 2010, Jefferson’s Kimmel Cancer Center co-sponsored with the Breast Health International  a Breast Cancer Consensus Conference.  The conference brought leading breast cancer experts from around the world together to discuss Adjuvant Therapy in Stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.

4
Nov

Breast Health International Held Annual Black Tie Gala

Breast Health International, a division of the Foundation for Breast & Prostate Health held it’s annual Black Tie Gala honoring Neiman Marcus and benefiting breast cancer research and development. The event was held on Friday, October 29. 2010 at the Rittenhouse Hotel in Downtown Philadelphia. Music was provided by the Eddie Bruce Band. A silent …

19
Oct

Dr. Mitchell & The KCC Host A Program On Triple Negative Breast Cancer Awareness

On Saturday, October 9th, 2010, Dr. Edith P. Mitchell and the Kimmel Cancer Center hosted a special program about triple-negative breast cancer (TNBC).  TNBC accounts for approximately 15% to 20% of breast cancer diagnoses but has twice the rate of prevalence among young women, particularly pre-menopausal African-American women. This program is designed to increase your …

14
Oct

Dr. Pestell and the Thomas Jefferson University Hospital to be honored by the Susan G. Komen for the Cure

Dr. Richard Pestell, Director of the Kimmel Cancer Center at Jefferson, will receive the “Light of Life” award at the 2010 Susan G. Komen Pink Tie Ball on Saturday, October 16.  Also that evening the “Beacon of Hope” award to the Thomas Jefferson University Hospital  will be accepted by Thomas J. Lewis, President and CEO, …

23
Sep

The Ramblewood Country Club Hosted John Runyan’s 2010 “Score For The Cure” Golf Tournament

The Ramblewood  Country Club in Mount Laurel, NJ hosted John Runyan’s 2010 “Score For The Cure” Golf Tournament on September 21st 2010. The proceeds benefited the Kimmel Cancer Center of Jefferson. Dietz & Watson was the Title Sponsor of the event. This  marks the 6th year of the event which has raised nearly $1,000,000 in …

Page 4 of 5